C.R. Bard, Inc. - 2004 dated Specimen Stock Certificate

Specimen Stock printed by Security-Columbian United States Banknote Corporation. Incorporated in 1972. C. R. Bard, Inc., based in Murray Hill, New Jersey, USA, was engaged in the development, manufacturing, and marketing of medical technologies across various fields, including vascular medicine, urology, oncology, and surgical specialties. The company distributed its products and services globally to hospitals, healthcare professionals, extended care facilities, and alternative care sites. As a member of the S&P 500 with approximately 14,000 employees in 2015, Bard is particularly recognized for the introduction of the Foley catheter in 1934.

In April 2017, C. R. Bard announced its acquisition by Becton, Dickinson and Company (BD), a transaction that was finalized later that year, resulting in Bard becoming a wholly-owned subsidiary of BD and undergoing rebranding. Founded in 1907 in New York City by Charles R. Bard, the company initially focused on importing Gomenol, a treatment for urinary discomfort. Bard was formally incorporated in 1923, and in 1926, Charles R. Bard sold the company to John F. Willits and Edson L. Outwin for $18,000. Under their leadership, the company expanded into the catheter market, launching the Foley catheter in 1934 and the America Woven Catheter in 1940.